More importantly, the tumor regression and improved survival were found in the CD73−/− hosts following anti-4-1BB treatment (Fig. 1a, b), suggesting that CD73 expressed by host cells suppresses the antitumor effect of anti–4-1BB therapy in the B16-SIY model. This evidence concerns the gene NT5E and neoplasm.